US 9994584
Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid
granted A61KA61K31/496
Quick answer
US patent 9994584 (Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid) held by Lixte Biotechnology, Inc. expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lixte Biotechnology, Inc.
- Grant date
- Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/496